Earnings Call Insights: Claritev Corporation (CTEV) Q1 2026
MANAGEMENT VIEW
* "We’re entering this year with confidence, confidence in our business, in our strategy and the durability of the foundation that we built." (CEO, President & Chairman Travis Dalton)
* "Our growth team had a strong start to the year, closing more than $40 million in annual contract value bookings in Q1" and Dalton said this supports "our $80 million to $100 million ACV sales target for this year." (CEO, President & Chairman Dalton)
* "At our Investor Day in March, we announced that we had signed an agreement with GDIT to provide a custom network for the World Trade Center Health Program" and Dalton added it "represents two important evolutions in the business" including "a new market, the public sector." (CEO, President & Chairman Dalton)
* "Total revenue in the quarter was $244.7 million, up 5.8% year-over-year" and "Adjusted EBITDA was $146.9 million for the quarter, up 3.4% year-over-year at a 60% margin." (Executive VP & CFO Doug Garis)
OUTLOOK
* "We are raising the bottom end of our guide range by -- revenue guide range by $5 million with a new range of $985 million to $1 billion." (Executive VP & CFO Garis)
* "We are maintaining full year adjusted EBITDA guidance of $605 million to $615 million with margins of 61% to 62%." (Executive VP & CFO Garis)
* "We expect Q2 revenue to be relatively flat sequentially" and "we expect our growth rate to increase to between 3% to 5% for the second half of the year." (Executive VP & CFO Garis)
* The transcript did not include EPS guidance figures; analyst-estimate comparisons are therefore omitted.
FINANCIAL RESULTS
* "In Q1, we outperformed our internal expectations for revenue, adjusted EBITDA and ACV." (Executive VP & CFO Garis)
* "In particular, we saw a solid outperformance in our flagship reference-based pricing solution Data iSight within claims intelligence service line, which in total was up 8.4% in the quarter." (Executive VP & CFO Garis)
* "We generated $36.8 million of unlevered free cash flow" and Garis also said the quarter had "a use of $92.5 million of free cash flow" while reiterating that "we expect Q1 and Q3 to be cash consumption quarters and Q2 and Q4 to be cash-generating quarters." (Executive VP & CFO Garis)
* "With $44.1 million of bookings in Q1, we are well on track" for the "$80 million to $100 million" ACV target; "pipeline growth remained strong, increasing 70% year-over-year" and the company "closed 9 deals over $1 million ACV." (Executive VP & CFO Garis)
Q&A
* Jason Cassorla, Guggenheim Securities, LLC, Research Division: asked about "puts and takes in terms of margins" as investments ramp; Executive VP & CFO Garis said investments began in Q4, guidance is "a pretty tight guide range," and "I would expect us to keep stable, if not slightly improving margins in the back half." (Executive VP & CFO Garis)
* Cassorla, Guggenheim Securities, LLC, Research Division: asked about utilization and rate/mix; Executive VP & CFO Garis cited "strong performance on a savings, identified savings and revenue and savings per claim" and said "nothing in the quarter kind of indicated that there was an aberration." (Executive VP & CFO Garis)
* Jessica Tassan, Piper Sandler & Co., Research Division: asked about services bookings mix and margins; Executive VP & CFO Garis said provider and public sector were "about 20% of the bookings" and "we expect margins to be roughly kind of half the core business as we ramp and scale." (Executive VP & CFO Garis)
* Tassan, Piper Sandler & Co., Research Division: asked about Medicare Advantage final rule impacts; CEO, President & Chairman Dalton responded, "Limited impact" and "limited if close to 0 volume impact." (CEO, President & Chairman Dalton)
* Stanislav Berenshteyn, Wells Fargo Securities, LLC, Research Division: asked about ACV visibility and mix; Executive VP & CFO Garis said core remains dominant, the funnel is "multi-nine figures," and "we feel very confident with the $80 million to $100 million on the full year." (Executive VP & CFO Garis)
* Berenshteyn, Wells Fargo Securities, LLC, Research Division: asked if Medicare Advantage pressure is driving demand; Executive VP & CFO Garis said, "Yes, absolutely" and added that "maybe 25% to 1/3 of the opportunities are in payment revenue integrity." (Executive VP & CFO Garis)
SENTIMENT ANALYSIS
* Analysts: slightly negative to neutral in tone, pressing on margins, utilization, and Medicare Advantage rule exposure (e.g., "help with the puts and takes," and "any color on the utilization environment"). (Jason Cassorla, Guggenheim Securities, LLC, Research Division)
* Management: slightly positive and confident, repeatedly emphasizing visibility and execution (e.g., "we are well on track," "we feel very confident," and "we’re confident in our year"). (Executive VP & CFO Garis; CEO, President & Chairman Dalton)
* Versus the previous quarter, the current call included full Q&A engagement and more detailed operating color; the prior quarter transcript ended early due to technical issues ("we will cut the call now"). (Vice President of Investor Relations Todd Friedman)
QUARTER-OVER-QUARTER COMPARISON
* Guidance language tightened upward on revenue in Q1 ("raising the bottom end" to "$985 million to $1 billion") compared with Q4’s initiation of 2026 revenue guidance of "$980 million to $1 billion." (Executive VP & CFO Doug Garis)
* ACV/bookings commentary escalated from Q4’s "bookings of $23 million in Q4" and expectation of "strong double-digit ACV bookings growth" to Q1’s "$44.1 million of bookings" and management stating it is "well on track" to the "$80 million to $100 million" target. (CEO, President & Chairman Travis Dalton; Executive VP & CFO Garis)
* Strategic emphasis remained consistent on AI and diversification, but Q1 added concrete partner/client wins (GDIT/World Trade Center Health Program; a "top 5 health system") and specific internal productivity claims ("nearly doubling coding capacity" with AI tools). (CEO, President & Chairman Dalton)
RISKS AND CONCERNS
* "Remember when building your models" that "the second, third and fourth quarters of '25 each had approximately $5.4 million of onetime revenue" that will affect comparisons. (Executive VP & CFO Garis)
* Cash flow seasonality remained a constraint: "we expect Q1 and Q3 to be cash consumption quarters." (Executive VP & CFO Garis)
* Services margin profile was flagged as structurally lower during ramp: "roughly kind of half the core business." (Executive VP & CFO Garis)
FINAL TAKEAWAY
Management framed Q1 as a start to 2026 with raised revenue guidance to $985 million to $1 billion while maintaining adjusted EBITDA guidance of $605 million to $615 million, supported by $44.1 million in bookings, growing pipeline, and new vertical wins in public sector and providers; leadership also emphasized investment pacing, expected second-half acceleration to 3% to 5% growth, and continued focus on AI-driven operating leverage and longer-term deleveraging.
Read the full Earnings Call Transcript [https://seekingalpha.com/symbol/ctev/earnings/transcripts]
MORE ON CLARITEV
* Claritev Corporation (CTEV) Q1 2026 Earnings Call Transcript [https://seekingalpha.com/article/4900563-claritev-corporation-ctev-q1-2026-earnings-call-transcript]
* Claritev Corporation 2026 Q1 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4900478-claritev-corporation-2026-q1-results-earnings-call-presentation]
* Claritev: Compounding Debt Meets Legacy Business Stabilization (Rating Upgrade) [https://seekingalpha.com/article/4891953-claritev-stock-compounding-debt-meets-legacy-business-stabilization-rating-upgrade]
* Claritev GAAP EPS of -$4.41 misses by $0.34, revenue of $244.7M beats by $6.11M [https://seekingalpha.com/news/4588095-claritev-gaap-eps-of-4_41-misses-by-0_34-revenue-of-244_7m-beats-by-6_11m]
* Claritev outlines 2026 revenue guidance of $980M–$1B as digital transformation accelerates [https://seekingalpha.com/news/4555641-claritev-outlines-2026-revenue-guidance-of-980m-1b-as-digital-transformation-accelerates]
文章加载中…